APO Research
Talk to an analyst

APO RESEARCH · REPORT

COVID-19 Rapid Antigen Test Kits

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global COVID-19 Rapid Antigen Test Kits Market Outlook and Growth Opportunities 2026

29 December 2025215 pages

Choose your research edition.

Industry ResearchCOVID-19 Rapid Antigen Test Kits Industry Research Report 2026151 pages · $2,950 USDIndustry Growth & TrendsGlobal COVID-19 Rapid Antigen Test Kits Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal COVID-19 Rapid Antigen Test Kits Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal COVID-19 Rapid Antigen Test Kits Market Outlook and Growth Opportunities 2026215 pages · $4,250 USDMarket Analysis & ForecastGlobal COVID-19 Rapid Antigen Test Kits Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

The global COVID-19 Rapid Antigen Test Kits market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for COVID-19 Rapid Antigen Test Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for COVID-19 Rapid Antigen Test Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for COVID-19 Rapid Antigen Test Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the COVID-19 Rapid Antigen Test Kits market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the COVID-19 Rapid Antigen Test Kits market include Shenzhen YHLO Biotech, Abbott, Wantai BioPharm, Wondfo Biotech, Beijing Hotgen Biotech, Vazyme Biotech, EasyDiagnosis Biomedicine, ROCHE and Lepu Medical Technology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global COVID-19 Rapid Antigen Test Kits market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of COVID-19 Rapid Antigen Test Kits and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents COVID-19 Rapid Antigen Test Kits sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the COVID-19 Rapid Antigen Test Kits market size, projected growth trends, production technologies, key applications, and end-use industries.

COVID-19 Rapid Antigen Test Kits Segment by Company

Shenzhen YHLO Biotech

Abbott

Wantai BioPharm

Wondfo Biotech

Beijing Hotgen Biotech

Vazyme Biotech

EasyDiagnosis Biomedicine

ROCHE

Lepu Medical Technology

BGI Genomics

Orient Gene

Biotest Biotech

Hangzhou AllTest Biotech

Assure Tech

ACON Biotech

SD Biosensor

RapiGEN Inc.

Quidel

Princeton BioMeditech Corporation

OraSure Technologies

LumiraDx

InBios

Ihealth (Andon Health)

Ellume

CTK Biotech

Clip Health

Celltrion

BD

AESKU.GROUP

ACCESS BIO

COVID-19 Rapid Antigen Test Kits Segment by Type

Colloidal Gold Immunochromatography

Latex Immunochromatography

Fluorescence Immunochromatography

Others

COVID-19 Rapid Antigen Test Kits Segment by Application

Hospital

School

Third-Party Detection Institution

Home

Others

COVID-19 Rapid Antigen Test Kits Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global COVID-19 Rapid Antigen Test Kits status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions COVID-19 Rapid Antigen Test Kits market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify COVID-19 Rapid Antigen Test Kits significant trends, drivers, influence factors in global and regions.

6. To analyze COVID-19 Rapid Antigen Test Kits competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global COVID-19 Rapid Antigen Test Kits market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of COVID-19 Rapid Antigen Test Kits and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of COVID-19 Rapid Antigen Test Kits.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the COVID-19 Rapid Antigen Test Kits market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global COVID-19 Rapid Antigen Test Kits industry.

Chapter 3: Detailed analysis of COVID-19 Rapid Antigen Test Kits manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of COVID-19 Rapid Antigen Test Kits in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of COVID-19 Rapid Antigen Test Kits in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. COVID-19 Rapid Antigen Test Kits Industry Trends Table 2. COVID-19 Rapid Antigen Test Kits Industry Drivers Table 3. COVID-19 Rapid Antigen Test Kits Industry Opportunities and Challenges Table 4. COVID-19 Rapid Antigen Test Kits Industry Restraints Table 5. Global COVID-19 Rapid Antigen Test Kits Revenue by Company (US$ Million) & (2021-2026) Table 6. Global COVID-19 Rapid Antigen Test Kits Revenue Share by Company (2021-2026) Table 7. Global COVID-19 Rapid Antigen Test Kits Sales Volume by Company (M Units) & (2021-2026) Table 8. Global COVID-19 Rapid Antigen Test Kits Sales Volume Share by Company (2021-2026) Table 9. Global COVID-19 Rapid Antigen Test Kits Average Price (US$/Unit) of Company (2021-2026) Table 10. Global COVID-19 Rapid Antigen Test Kits Company Ranking, (2024-2026) & (USD Million) Table 11. Global COVID-19 Rapid Antigen Test Kits Key Company Manufacturing Base & Headquarters Table 12. Global COVID-19 Rapid Antigen Test Kits Company, Product Type & Application Table 13. Global COVID-19 Rapid Antigen Test Kits Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global COVID-19 Rapid Antigen Test Kits by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Colloidal Gold Immunochromatography Table 18. Significant Companies of Latex Immunochromatography Table 19. Significant Companies of Fluorescence Immunochromatography Table 20. Significant Companies of Others Table 21. Global COVID-19 Rapid Antigen Test Kits Sales Volume by Type 2021 VS 2025 VS 2032 (M Units) Table 22. Global COVID-19 Rapid Antigen Test Kits Sales Volume by Type (2021-2026) & (M Units) Table 23. Global COVID-19 Rapid Antigen Test Kits Sales Volume by Type (2027-2032) & (M Units) Table 24. Global COVID-19 Rapid Antigen Test Kits Sales Volume Share by Type (2021-2026) Table 25. Global COVID-19 Rapid Antigen Test Kits Sales Volume Share by Type (2027-2032) Table 26. Global COVID-19 Rapid Antigen Test Kits Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global COVID-19 Rapid Antigen Test Kits Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global COVID-19 Rapid Antigen Test Kits Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global COVID-19 Rapid Antigen Test Kits Sales Value Share by Type (2021-2026) Table 30. Global COVID-19 Rapid Antigen Test Kits Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Hospital Table 32. Significant Companies of School Table 33. Significant Companies of Third-Party Detection Institution Table 34. Significant Companies of Home Table 35. Significant Companies of Others Table 36. Global COVID-19 Rapid Antigen Test Kits Sales Volume by Application 2021 VS 2025 VS 2032 (M Units) Table 37. Global COVID-19 Rapid Antigen Test Kits Sales Volume by Application (2021-2026) & (M Units) Table 38. Global COVID-19 Rapid Antigen Test Kits Sales Volume by Application (2027-2032) & (M Units) Table 39. Global COVID-19 Rapid Antigen Test Kits Sales Volume Share by Application (2021-2026) Table 40. Global COVID-19 Rapid Antigen Test Kits Sales Volume Share by Application (2027-2032) Table 41. Global COVID-19 Rapid Antigen Test Kits Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global COVID-19 Rapid Antigen Test Kits Sales Value by Application (2021-2026) & (US$ Million) Table 43. Global COVID-19 Rapid Antigen Test Kits Sales Value by Application (2027-2032) & (US$ Million) Table 44. Global COVID-19 Rapid Antigen Test Kits Sales Value Share by Application (2021-2026) Table 45. Global COVID-19 Rapid Antigen Test Kits Sales Value Share by Application (2027-2032) Table 46. Global COVID-19 Rapid Antigen Test Kits Sales by Region: 2021 VS 2025 VS 2032 (M Units) Table 47. Global COVID-19 Rapid Antigen Test Kits Sales by Region (2021-2026) & (M Units) Table 48. Global COVID-19 Rapid Antigen Test Kits Sales Market Share by Region (2021-2026) Table 49. Global COVID-19 Rapid Antigen Test Kits Sales by Region (2027-2032) & (M Units) Table 50. Global COVID-19 Rapid Antigen Test Kits Sales Market Share by Region (2027-2032) Table 51. Global COVID-19 Rapid Antigen Test Kits Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global COVID-19 Rapid Antigen Test Kits Sales Value by Region (2021-2026) & (US$ Million) Table 53. Global COVID-19 Rapid Antigen Test Kits Sales Value Share by Region (2021-2026) Table 54. Global COVID-19 Rapid Antigen Test Kits Sales Value by Region (2027-2032) & (US$ Million) Table 55. Global COVID-19 Rapid Antigen Test Kits Sales Value Share by Region (2027-2032) Table 56. Global COVID-19 Rapid Antigen Test Kits Market Average Price (US$/Unit) by Region (2021-2026) Table 57. Global COVID-19 Rapid Antigen Test Kits Market Average Price (US$/Unit) by Region (2027-2032) Table 58. Global COVID-19 Rapid Antigen Test Kits Sales by Country: 2021 VS 2025 VS 2032 (M Units) Table 59. Global COVID-19 Rapid Antigen Test Kits Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global COVID-19 Rapid Antigen Test Kits Sales by Country (2021-2026) & (M Units) Table 61. Global COVID-19 Rapid Antigen Test Kits Sales Market Share by Country (2021-2026) Table 62. Global COVID-19 Rapid Antigen Test Kits Sales by Country (2027-2032) & (M Units) Table 63. Global COVID-19 Rapid Antigen Test Kits Sales Market Share by Country (2027-2032) Table 64. Global COVID-19 Rapid Antigen Test Kits Sales Value by Country (2021-2026) & (US$ Million) Table 65. Global COVID-19 Rapid Antigen Test Kits Sales Value Market Share by Country (2021-2026) Table 66. Global COVID-19 Rapid Antigen Test Kits Sales Value by Country (2027-2032) & (US$ Million) Table 67. Global COVID-19 Rapid Antigen Test Kits Sales Value Market Share by Country (2027-2032) Table 68. Shenzhen YHLO Biotech Company Information Table 69. Shenzhen YHLO Biotech Business Overview Table 70. Shenzhen YHLO Biotech COVID-19 Rapid Antigen Test Kits Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Shenzhen YHLO Biotech COVID-19 Rapid Antigen Test Kits Product Portfolio Table 72. Shenzhen YHLO Biotech Recent Development Table 73. Abbott Company Information Table 74. Abbott Business Overview Table 75. Abbott COVID-19 Rapid Antigen Test Kits Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Abbott COVID-19 Rapid Antigen Test Kits Product Portfolio Table 77. Abbott Recent Development Table 78. Wantai BioPharm Company Information Table 79. Wantai BioPharm Business Overview Table 80. Wantai BioPharm COVID-19 Rapid Antigen Test Kits Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Wantai BioPharm COVID-19 Rapid Antigen Test Kits Product Portfolio Table 82. Wantai BioPharm Recent Development Table 83. Wondfo Biotech Company Information Table 84. Wondfo Biotech Business Overview Table 85. Wondfo Biotech COVID-19 Rapid Antigen Test Kits Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Wondfo Biotech COVID-19 Rapid Antigen Test Kits Product Portfolio Table 87. Wondfo Biotech Recent Development Table 88. Beijing Hotgen Biotech Company Information Table 89. Beijing Hotgen Biotech Business Overview Table 90. Beijing Hotgen Biotech COVID-19 Rapid Antigen Test Kits Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Beijing Hotgen Biotech COVID-19 Rapid Antigen Test Kits Product Portfolio Table 92. Beijing Hotgen Biotech Recent Development Table 93. Vazyme Biotech Company Information Table 94. Vazyme Biotech Business Overview Table 95. Vazyme Biotech COVID-19 Rapid Antigen Test Kits Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Vazyme Biotech COVID-19 Rapid Antigen Test Kits Product Portfolio Table 97. Vazyme Biotech Recent Development Table 98. EasyDiagnosis Biomedicine Company Information Table 99. EasyDiagnosis Biomedicine Business Overview Table 100. EasyDiagnosis Biomedicine COVID-19 Rapid Antigen Test Kits Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. EasyDiagnosis Biomedicine COVID-19 Rapid Antigen Test Kits Product Portfolio Table 102. EasyDiagnosis Biomedicine Recent Development Table 103. ROCHE Company Information Table 104. ROCHE Business Overview Table 105. ROCHE COVID-19 Rapid Antigen Test Kits Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. ROCHE COVID-19 Rapid Antigen Test Kits Product Portfolio Table 107. ROCHE Recent Development Table 108. Lepu Medical Technology Company Information Table 109. Lepu Medical Technology Business Overview Table 110. Lepu Medical Technology COVID-19 Rapid Antigen Test Kits Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Lepu Medical Technology COVID-19 Rapid Antigen Test Kits Product Portfolio Table 112. Lepu Medical Technology Recent Development Table 113. BGI Genomics Company Information Table 114. BGI Genomics Business Overview Table 115. BGI Genomics COVID-19 Rapid Antigen Test Kits Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. BGI Genomics COVID-19 Rapid Antigen Test Kits Product Portfolio Table 117. BGI Genomics Recent Development Table 118. Orient Gene Company Information Table 119. Orient Gene Business Overview Table 120. Orient Gene COVID-19 Rapid Antigen Test Kits Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Orient Gene COVID-19 Rapid Antigen Test Kits Product Portfolio Table 122. Orient Gene Recent Development Table 123. Biotest Biotech Company Information Table 124. Biotest Biotech Business Overview Table 125. Biotest Biotech COVID-19 Rapid Antigen Test Kits Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Biotest Biotech COVID-19 Rapid Antigen Test Kits Product Portfolio Table 127. Biotest Biotech Recent Development Table 128. Hangzhou AllTest Biotech Company Information Table 129. Hangzhou AllTest Biotech Business Overview Table 130. Hangzhou AllTest Biotech COVID-19 Rapid Antigen Test Kits Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Hangzhou AllTest Biotech COVID-19 Rapid Antigen Test Kits Product Portfolio Table 132. Hangzhou AllTest Biotech Recent Development Table 133. Assure Tech Company Information Table 134. Assure Tech Business Overview Table 135. Assure Tech COVID-19 Rapid Antigen Test Kits Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Assure Tech COVID-19 Rapid Antigen Test Kits Product Portfolio Table 137. Assure Tech Recent Development Table 138. ACON Biotech Company Information Table 139. ACON Biotech Business Overview Table 140. ACON Biotech COVID-19 Rapid Antigen Test Kits Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. ACON Biotech COVID-19 Rapid Antigen Test Kits Product Portfolio Table 142. ACON Biotech Recent Development Table 143. SD Biosensor Company Information Table 144. SD Biosensor Business Overview Table 145. SD Biosensor COVID-19 Rapid Antigen Test Kits Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 146. SD Biosensor COVID-19 Rapid Antigen Test Kits Product Portfolio Table 147. SD Biosensor Recent Development Table 148. RapiGEN Inc. Company Information Table 149. RapiGEN Inc. Business Overview Table 150. RapiGEN Inc. COVID-19 Rapid Antigen Test Kits Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 151. RapiGEN Inc. COVID-19 Rapid Antigen Test Kits Product Portfolio Table 152. RapiGEN Inc. Recent Development Table 153. Quidel Company Information Table 154. Quidel Business Overview Table 155. Quidel COVID-19 Rapid Antigen Test Kits Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 156. Quidel COVID-19 Rapid Antigen Test Kits Product Portfolio Table 157. Quidel Recent Development Table 158. Princeton BioMeditech Corporation Company Information Table 159. Princeton BioMeditech Corporation Business Overview Table 160. Princeton BioMeditech Corporation COVID-19 Rapid Antigen Test Kits Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 161. Princeton BioMeditech Corporation COVID-19 Rapid Antigen Test Kits Product Portfolio Table 162. Princeton BioMeditech Corporation Recent Development Table 163. OraSure Technologies Company Information Table 164. OraSure Technologies Business Overview Table 165. OraSure Technologies COVID-19 Rapid Antigen Test Kits Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 166. OraSure Technologies COVID-19 Rapid Antigen Test Kits Product Portfolio Table 167. OraSure Technologies Recent Development Table 168. LumiraDx Company Information Table 169. LumiraDx Business Overview Table 170. LumiraDx COVID-19 Rapid Antigen Test Kits Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 171. LumiraDx COVID-19 Rapid Antigen Test Kits Product Portfolio Table 172. LumiraDx Recent Development Table 173. InBios Company Information Table 174. InBios Business Overview Table 175. InBios COVID-19 Rapid Antigen Test Kits Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 176. InBios COVID-19 Rapid Antigen Test Kits Product Portfolio Table 177. InBios Recent Development Table 178. Ihealth (Andon Health) Company Information Table 179. Ihealth (Andon Health) Business Overview Table 180. Ihealth (Andon Health) COVID-19 Rapid Antigen Test Kits Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 181. Ihealth (Andon Health) COVID-19 Rapid Antigen Test Kits Product Portfolio Table 182. Ihealth (Andon Health) Recent Development Table 183. Ellume Company Information Table 184. Ellume Business Overview Table 185. Ellume COVID-19 Rapid Antigen Test Kits Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 186. Ellume COVID-19 Rapid Antigen Test Kits Product Portfolio Table 187. Ellume Recent Development Table 188. CTK Biotech Company Information Table 189. CTK Biotech Business Overview Table 190. CTK Biotech COVID-19 Rapid Antigen Test Kits Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 191. CTK Biotech COVID-19 Rapid Antigen Test Kits Product Portfolio Table 192. CTK Biotech Recent Development Table 193. Clip Health Company Information Table 194. Clip Health Business Overview Table 195. Clip Health COVID-19 Rapid Antigen Test Kits Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 196. Clip Health COVID-19 Rapid Antigen Test Kits Product Portfolio Table 197. Clip Health Recent Development Table 198. Celltrion Company Information Table 199. Celltrion Business Overview Table 200. Celltrion COVID-19 Rapid Antigen Test Kits Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 201. Celltrion COVID-19 Rapid Antigen Test Kits Product Portfolio Table 202. Celltrion Recent Development Table 203. BD Company Information Table 204. BD Business Overview Table 205. BD COVID-19 Rapid Antigen Test Kits Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 206. BD COVID-19 Rapid Antigen Test Kits Product Portfolio Table 207. BD Recent Development Table 208. AESKU.GROUP Company Information Table 209. AESKU.GROUP Business Overview Table 210. AESKU.GROUP COVID-19 Rapid Antigen Test Kits Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 211. AESKU.GROUP COVID-19 Rapid Antigen Test Kits Product Portfolio Table 212. AESKU.GROUP Recent Development Table 213. ACCESS BIO Company Information Table 214. ACCESS BIO Business Overview Table 215. ACCESS BIO COVID-19 Rapid Antigen Test Kits Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 216. ACCESS BIO COVID-19 Rapid Antigen Test Kits Product Portfolio Table 217. ACCESS BIO Recent Development Table 218. Key Raw Materials Table 219. Raw Materials Key Suppliers Table 220. COVID-19 Rapid Antigen Test Kits Distributors List Table 221. COVID-19 Rapid Antigen Test Kits Customers List Table 222. Research Programs/Design for This Report Table 223. Authors List of This Report Table 224. Secondary Sources Table 225. Primary Sources List of Figures Figure 1. COVID-19 Rapid Antigen Test Kits Product Image Figure 2. Global COVID-19 Rapid Antigen Test Kits Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global COVID-19 Rapid Antigen Test Kits Sales Value (2021-2032) & (US$ Million) Figure 4. Global COVID-19 Rapid Antigen Test Kits Sales (2021-2032) & (M Units) Figure 5. Global COVID-19 Rapid Antigen Test Kits Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global COVID-19 Rapid Antigen Test Kits Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Colloidal Gold Immunochromatography Image Figure 10. Latex Immunochromatography Image Figure 11. Fluorescence Immunochromatography Image Figure 12. Others Image Figure 13. Global COVID-19 Rapid Antigen Test Kits Sales Volume by Type (2021 VS 2025 VS 2032) & (M Units) Figure 14. Global COVID-19 Rapid Antigen Test Kits Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global COVID-19 Rapid Antigen Test Kits Sales Volume Share by Type (2021-2032) Figure 16. Global COVID-19 Rapid Antigen Test Kits Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global COVID-19 Rapid Antigen Test Kits Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global COVID-19 Rapid Antigen Test Kits Sales Value Share by Type (2021-2032) Figure 19. Hospital Image Figure 20. School Image Figure 21. Third-Party Detection Institution Image Figure 22. Home Image Figure 23. Others Image Figure 24. Global COVID-19 Rapid Antigen Test Kits Sales Volume by Application (2021 VS 2025 VS 2032) & (M Units) Figure 25. Global COVID-19 Rapid Antigen Test Kits Sales Volume Share 2021 VS 2025 VS 2032 Figure 26. Global COVID-19 Rapid Antigen Test Kits Sales Volume Share by Application (2021-2032) Figure 27. Global COVID-19 Rapid Antigen Test Kits Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global COVID-19 Rapid Antigen Test Kits Sales Value Share 2021 VS 2025 VS 2032 Figure 29. Global COVID-19 Rapid Antigen Test Kits Sales Value Share by Application (2021-2032) Figure 30. Global COVID-19 Rapid Antigen Test Kits Sales by Region: 2021 VS 2025 VS 2032 (M Units) Figure 31. Global COVID-19 Rapid Antigen Test Kits Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 32. Global COVID-19 Rapid Antigen Test Kits Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 33. Global COVID-19 Rapid Antigen Test Kits Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 34. North America COVID-19 Rapid Antigen Test Kits Sales Value (2021-2032) & (US$ Million) Figure 35. North America COVID-19 Rapid Antigen Test Kits Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Europe COVID-19 Rapid Antigen Test Kits Sales Value (2021-2032) & (US$ Million) Figure 37. Europe COVID-19 Rapid Antigen Test Kits Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Asia-Pacific COVID-19 Rapid Antigen Test Kits Sales Value (2021-2032) & (US$ Million) Figure 39. Asia-Pacific COVID-19 Rapid Antigen Test Kits Sales Value Share by Country (%), 2025 VS 2032 Figure 40. South America COVID-19 Rapid Antigen Test Kits Sales Value (2021-2032) & (US$ Million) Figure 41. South America COVID-19 Rapid Antigen Test Kits Sales Value Share by Country (%), 2025 VS 2032 Figure 42. Middle East & Africa COVID-19 Rapid Antigen Test Kits Sales Value (2021-2032) & (US$ Million) Figure 43. Middle East & Africa COVID-19 Rapid Antigen Test Kits Sales Value Share by Country (%), 2025 VS 2032 Figure 44. USA COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. USA COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. USA COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Canada COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Canada COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Canada COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Mexico COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Mexico COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Mexico COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Germany COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Germany COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Germany COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. France COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. France COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. France COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. U.K. COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. U.K. COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. U.K. COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Italy COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Italy COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Italy COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Spain COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Spain COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Spain COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Russia COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Russia COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Russia COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Netherlands COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Netherlands COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Netherlands COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Nordic Countries COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Nordic Countries COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Nordic Countries COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. China COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. China COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. China COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Japan COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Japan COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Japan COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. South Korea COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. South Korea COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. South Korea COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. India COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. India COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. India COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Australia COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Australia COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Australia COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Southeast Asia COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Southeast Asia COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Southeast Asia COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Brazil COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Brazil COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Brazil COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Argentina COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Argentina COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Argentina COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Chile COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Chile COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Chile COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Colombia COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Colombia COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Colombia COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Peru COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Peru COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Peru COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Saudi Arabia COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Saudi Arabia COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Saudi Arabia COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Israel COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Israel Arabia COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Israel Arabia COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. UAE COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. UAE COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. UAE COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Turkey COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Turkey COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Turkey COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Iran COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Iran COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Iran COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Egypt COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Egypt COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Egypt COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. COVID-19 Rapid Antigen Test Kits Value Chain Figure 129. Manufacturing Cost Structure Figure 130. COVID-19 Rapid Antigen Test Kits Sales Mode & Process Figure 131. Direct Comparison with Distribution Share Figure 132. Distributors Profiles Figure 133. Years Considered Figure 134. Research Process Figure 135. Key Executives Interviewed

Scope & coverage.

Types
  • Colloidal Gold Immunochromatography
  • Latex Immunochromatography
  • Fluorescence Immunochromatography
  • Others
Applications
  • Hospital
  • School
  • Third-Party Detection Institution
  • Home
  • Others
Companies covered
  • Shenzhen YHLO Biotech
  • Abbott
  • Wantai BioPharm
  • Wondfo Biotech
  • Beijing Hotgen Biotech
  • Vazyme Biotech
  • EasyDiagnosis Biomedicine
  • ROCHE
  • Lepu Medical Technology
  • BGI Genomics
  • Orient Gene
  • Biotest Biotech
  • Hangzhou AllTest Biotech
  • Assure Tech
  • ACON Biotech
  • SD Biosensor
  • RapiGEN Inc.
  • Quidel
  • Princeton BioMeditech Corporation
  • OraSure Technologies
  • LumiraDx
  • InBios
  • Ihealth (Andon Health)
  • Ellume
  • CTK Biotech
  • Clip Health
  • Celltrion
  • BD
  • AESKU.GROUP
  • ACCESS BIO

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global COVID-19 Rapid Antigen Test Kits Sales Value (2021-2032)
  4. 1.2.2 Global COVID-19 Rapid Antigen Test Kits Sales Volume (2021-2032)
  5. 1.2.3 Global COVID-19 Rapid Antigen Test Kits Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 COVID-19 Rapid Antigen Test Kits Market Dynamics
  1. 2.1 COVID-19 Rapid Antigen Test Kits Industry Trends
  2. 2.2 COVID-19 Rapid Antigen Test Kits Industry Drivers
  3. 2.3 COVID-19 Rapid Antigen Test Kits Industry Opportunities and Challenges
  4. 2.4 COVID-19 Rapid Antigen Test Kits Industry Restraints
3 COVID-19 Rapid Antigen Test Kits Market by Company
  1. 3.1 Global COVID-19 Rapid Antigen Test Kits Company Revenue Ranking in 2025
  2. 3.2 Global COVID-19 Rapid Antigen Test Kits Revenue by Company (2021-2026)
  3. 3.3 Global COVID-19 Rapid Antigen Test Kits Sales Volume by Company (2021-2026)
  4. 3.4 Global COVID-19 Rapid Antigen Test Kits Average Price by Company (2021-2026)
  5. 3.5 Global COVID-19 Rapid Antigen Test Kits Company Ranking (2024-2026)
  6. 3.6 Global COVID-19 Rapid Antigen Test Kits Company Manufacturing Base and Headquarters
  7. 3.7 Global COVID-19 Rapid Antigen Test Kits Company Product Type and Application
  8. 3.8 Global COVID-19 Rapid Antigen Test Kits Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global COVID-19 Rapid Antigen Test Kits Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 COVID-19 Rapid Antigen Test Kits Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 COVID-19 Rapid Antigen Test Kits Market by Type
  1. 4.1 COVID-19 Rapid Antigen Test Kits Type Introduction
  2. 4.1.1 Colloidal Gold Immunochromatography
  3. 4.1.2 Latex Immunochromatography
  4. 4.1.3 Fluorescence Immunochromatography
  5. 4.1.4 Others
  6. 4.2 Global COVID-19 Rapid Antigen Test Kits Sales Volume by Type
  7. 4.2.1 Global COVID-19 Rapid Antigen Test Kits Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global COVID-19 Rapid Antigen Test Kits Sales Volume by Type (2021-2032)
  9. 4.2.3 Global COVID-19 Rapid Antigen Test Kits Sales Volume Share by Type (2021-2032)
  10. 4.3 Global COVID-19 Rapid Antigen Test Kits Sales Value by Type
  11. 4.3.1 Global COVID-19 Rapid Antigen Test Kits Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global COVID-19 Rapid Antigen Test Kits Sales Value by Type (2021-2032)
  13. 4.3.3 Global COVID-19 Rapid Antigen Test Kits Sales Value Share by Type (2021-2032)
5 COVID-19 Rapid Antigen Test Kits Market by Application
  1. 5.1 COVID-19 Rapid Antigen Test Kits Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 School
  4. 5.1.3 Third-Party Detection Institution
  5. 5.1.4 Home
  6. 5.1.5 Others
  7. 5.2 Global COVID-19 Rapid Antigen Test Kits Sales Volume by Application
  8. 5.2.1 Global COVID-19 Rapid Antigen Test Kits Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global COVID-19 Rapid Antigen Test Kits Sales Volume by Application (2021-2032)
  10. 5.2.3 Global COVID-19 Rapid Antigen Test Kits Sales Volume Share by Application (2021-2032)
  11. 5.3 Global COVID-19 Rapid Antigen Test Kits Sales Value by Application
  12. 5.3.1 Global COVID-19 Rapid Antigen Test Kits Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global COVID-19 Rapid Antigen Test Kits Sales Value by Application (2021-2032)
  14. 5.3.3 Global COVID-19 Rapid Antigen Test Kits Sales Value Share by Application (2021-2032)
6 COVID-19 Rapid Antigen Test Kits Regional Sales and Value Analysis
  1. 6.1 Global COVID-19 Rapid Antigen Test Kits Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global COVID-19 Rapid Antigen Test Kits Sales by Region (2021-2032)
  3. 6.2.1 Global COVID-19 Rapid Antigen Test Kits Sales by Region: 2021-2026
  4. 6.2.2 Global COVID-19 Rapid Antigen Test Kits Sales by Region (2027-2032)
  5. 6.3 Global COVID-19 Rapid Antigen Test Kits Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global COVID-19 Rapid Antigen Test Kits Sales Value by Region (2021-2032)
  7. 6.4.1 Global COVID-19 Rapid Antigen Test Kits Sales Value by Region: 2021-2026
  8. 6.4.2 Global COVID-19 Rapid Antigen Test Kits Sales Value by Region (2027-2032)
  9. 6.5 Global COVID-19 Rapid Antigen Test Kits Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America COVID-19 Rapid Antigen Test Kits Sales Value (2021-2032)
  12. 6.6.2 North America COVID-19 Rapid Antigen Test Kits Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe COVID-19 Rapid Antigen Test Kits Sales Value (2021-2032)
  15. 6.7.2 Europe COVID-19 Rapid Antigen Test Kits Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific COVID-19 Rapid Antigen Test Kits Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific COVID-19 Rapid Antigen Test Kits Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America COVID-19 Rapid Antigen Test Kits Sales Value (2021-2032)
  21. 6.9.2 South America COVID-19 Rapid Antigen Test Kits Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa COVID-19 Rapid Antigen Test Kits Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa COVID-19 Rapid Antigen Test Kits Sales Value Share by Country, 2025 VS 2032
7 COVID-19 Rapid Antigen Test Kits Country-level Sales and Value Analysis
  1. 7.1 Global COVID-19 Rapid Antigen Test Kits Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global COVID-19 Rapid Antigen Test Kits Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global COVID-19 Rapid Antigen Test Kits Sales by Country (2021-2032)
  4. 7.3.1 Global COVID-19 Rapid Antigen Test Kits Sales by Country (2021-2026)
  5. 7.3.2 Global COVID-19 Rapid Antigen Test Kits Sales by Country (2027-2032)
  6. 7.4 Global COVID-19 Rapid Antigen Test Kits Sales Value by Country (2021-2032)
  7. 7.4.1 Global COVID-19 Rapid Antigen Test Kits Sales Value by Country (2021-2026)
  8. 7.4.2 Global COVID-19 Rapid Antigen Test Kits Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt COVID-19 Rapid Antigen Test Kits Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt COVID-19 Rapid Antigen Test Kits Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt COVID-19 Rapid Antigen Test Kits Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Shenzhen YHLO Biotech
  2. 8.1.1 Shenzhen YHLO Biotech Company Information
  3. 8.1.2 Shenzhen YHLO Biotech Business Overview
  4. 8.1.3 Shenzhen YHLO Biotech COVID-19 Rapid Antigen Test Kits Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Shenzhen YHLO Biotech COVID-19 Rapid Antigen Test Kits Product Portfolio
  6. 8.1.5 Shenzhen YHLO Biotech Recent Developments
  7. 8.2 Abbott
  8. 8.2.1 Abbott Company Information
  9. 8.2.2 Abbott Business Overview
  10. 8.2.3 Abbott COVID-19 Rapid Antigen Test Kits Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Abbott COVID-19 Rapid Antigen Test Kits Product Portfolio
  12. 8.2.5 Abbott Recent Developments
  13. 8.3 Wantai BioPharm
  14. 8.3.1 Wantai BioPharm Company Information
  15. 8.3.2 Wantai BioPharm Business Overview
  16. 8.3.3 Wantai BioPharm COVID-19 Rapid Antigen Test Kits Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Wantai BioPharm COVID-19 Rapid Antigen Test Kits Product Portfolio
  18. 8.3.5 Wantai BioPharm Recent Developments
  19. 8.4 Wondfo Biotech
  20. 8.4.1 Wondfo Biotech Company Information
  21. 8.4.2 Wondfo Biotech Business Overview
  22. 8.4.3 Wondfo Biotech COVID-19 Rapid Antigen Test Kits Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Wondfo Biotech COVID-19 Rapid Antigen Test Kits Product Portfolio
  24. 8.4.5 Wondfo Biotech Recent Developments
  25. 8.5 Beijing Hotgen Biotech
  26. 8.5.1 Beijing Hotgen Biotech Company Information
  27. 8.5.2 Beijing Hotgen Biotech Business Overview
  28. 8.5.3 Beijing Hotgen Biotech COVID-19 Rapid Antigen Test Kits Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Beijing Hotgen Biotech COVID-19 Rapid Antigen Test Kits Product Portfolio
  30. 8.5.5 Beijing Hotgen Biotech Recent Developments
  31. 8.6 Vazyme Biotech
  32. 8.6.1 Vazyme Biotech Company Information
  33. 8.6.2 Vazyme Biotech Business Overview
  34. 8.6.3 Vazyme Biotech COVID-19 Rapid Antigen Test Kits Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Vazyme Biotech COVID-19 Rapid Antigen Test Kits Product Portfolio
  36. 8.6.5 Vazyme Biotech Recent Developments
  37. 8.7 EasyDiagnosis Biomedicine
  38. 8.7.1 EasyDiagnosis Biomedicine Company Information
  39. 8.7.2 EasyDiagnosis Biomedicine Business Overview
  40. 8.7.3 EasyDiagnosis Biomedicine COVID-19 Rapid Antigen Test Kits Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 EasyDiagnosis Biomedicine COVID-19 Rapid Antigen Test Kits Product Portfolio
  42. 8.7.5 EasyDiagnosis Biomedicine Recent Developments
  43. 8.8 ROCHE
  44. 8.8.1 ROCHE Company Information
  45. 8.8.2 ROCHE Business Overview
  46. 8.8.3 ROCHE COVID-19 Rapid Antigen Test Kits Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 ROCHE COVID-19 Rapid Antigen Test Kits Product Portfolio
  48. 8.8.5 ROCHE Recent Developments
  49. 8.9 Lepu Medical Technology
  50. 8.9.1 Lepu Medical Technology Company Information
  51. 8.9.2 Lepu Medical Technology Business Overview
  52. 8.9.3 Lepu Medical Technology COVID-19 Rapid Antigen Test Kits Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Lepu Medical Technology COVID-19 Rapid Antigen Test Kits Product Portfolio
  54. 8.9.5 Lepu Medical Technology Recent Developments
  55. 8.10 BGI Genomics
  56. 8.10.1 BGI Genomics Company Information
  57. 8.10.2 BGI Genomics Business Overview
  58. 8.10.3 BGI Genomics COVID-19 Rapid Antigen Test Kits Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 BGI Genomics COVID-19 Rapid Antigen Test Kits Product Portfolio
  60. 8.10.5 BGI Genomics Recent Developments
  61. 8.11 Orient Gene
  62. 8.11.1 Orient Gene Company Information
  63. 8.11.2 Orient Gene Business Overview
  64. 8.11.3 Orient Gene COVID-19 Rapid Antigen Test Kits Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Orient Gene COVID-19 Rapid Antigen Test Kits Product Portfolio
  66. 8.11.5 Orient Gene Recent Developments
  67. 8.12 Biotest Biotech
  68. 8.12.1 Biotest Biotech Company Information
  69. 8.12.2 Biotest Biotech Business Overview
  70. 8.12.3 Biotest Biotech COVID-19 Rapid Antigen Test Kits Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Biotest Biotech COVID-19 Rapid Antigen Test Kits Product Portfolio
  72. 8.12.5 Biotest Biotech Recent Developments
  73. 8.13 Hangzhou AllTest Biotech
  74. 8.13.1 Hangzhou AllTest Biotech Company Information
  75. 8.13.2 Hangzhou AllTest Biotech Business Overview
  76. 8.13.3 Hangzhou AllTest Biotech COVID-19 Rapid Antigen Test Kits Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Hangzhou AllTest Biotech COVID-19 Rapid Antigen Test Kits Product Portfolio
  78. 8.13.5 Hangzhou AllTest Biotech Recent Developments
  79. 8.14 Assure Tech
  80. 8.14.1 Assure Tech Company Information
  81. 8.14.2 Assure Tech Business Overview
  82. 8.14.3 Assure Tech COVID-19 Rapid Antigen Test Kits Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Assure Tech COVID-19 Rapid Antigen Test Kits Product Portfolio
  84. 8.14.5 Assure Tech Recent Developments
  85. 8.15 ACON Biotech
  86. 8.15.1 ACON Biotech Company Information
  87. 8.15.2 ACON Biotech Business Overview
  88. 8.15.3 ACON Biotech COVID-19 Rapid Antigen Test Kits Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 ACON Biotech COVID-19 Rapid Antigen Test Kits Product Portfolio
  90. 8.15.5 ACON Biotech Recent Developments
  91. 8.16 SD Biosensor
  92. 8.16.1 SD Biosensor Company Information
  93. 8.16.2 SD Biosensor Business Overview
  94. 8.16.3 SD Biosensor COVID-19 Rapid Antigen Test Kits Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 SD Biosensor COVID-19 Rapid Antigen Test Kits Product Portfolio
  96. 8.16.5 SD Biosensor Recent Developments
  97. 8.17 RapiGEN Inc.
  98. 8.17.1 RapiGEN Inc. Company Information
  99. 8.17.2 RapiGEN Inc. Business Overview
  100. 8.17.3 RapiGEN Inc. COVID-19 Rapid Antigen Test Kits Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 RapiGEN Inc. COVID-19 Rapid Antigen Test Kits Product Portfolio
  102. 8.17.5 RapiGEN Inc. Recent Developments
  103. 8.18 Quidel
  104. 8.18.1 Quidel Company Information
  105. 8.18.2 Quidel Business Overview
  106. 8.18.3 Quidel COVID-19 Rapid Antigen Test Kits Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Quidel COVID-19 Rapid Antigen Test Kits Product Portfolio
  108. 8.18.5 Quidel Recent Developments
  109. 8.19 Princeton BioMeditech Corporation
  110. 8.19.1 Princeton BioMeditech Corporation Company Information
  111. 8.19.2 Princeton BioMeditech Corporation Business Overview
  112. 8.19.3 Princeton BioMeditech Corporation COVID-19 Rapid Antigen Test Kits Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Princeton BioMeditech Corporation COVID-19 Rapid Antigen Test Kits Product Portfolio
  114. 8.19.5 Princeton BioMeditech Corporation Recent Developments
  115. 8.20 OraSure Technologies
  116. 8.20.1 OraSure Technologies Company Information
  117. 8.20.2 OraSure Technologies Business Overview
  118. 8.20.3 OraSure Technologies COVID-19 Rapid Antigen Test Kits Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 OraSure Technologies COVID-19 Rapid Antigen Test Kits Product Portfolio
  120. 8.20.5 OraSure Technologies Recent Developments
  121. 8.21 LumiraDx
  122. 8.21.1 LumiraDx Company Information
  123. 8.21.2 LumiraDx Business Overview
  124. 8.21.3 LumiraDx COVID-19 Rapid Antigen Test Kits Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 LumiraDx COVID-19 Rapid Antigen Test Kits Product Portfolio
  126. 8.21.5 LumiraDx Recent Developments
  127. 8.22 InBios
  128. 8.22.1 InBios Company Information
  129. 8.22.2 InBios Business Overview
  130. 8.22.3 InBios COVID-19 Rapid Antigen Test Kits Sales, Value and Gross Margin (2021-2026)
  131. 8.22.4 InBios COVID-19 Rapid Antigen Test Kits Product Portfolio
  132. 8.22.5 InBios Recent Developments
  133. 8.23 Ihealth (Andon Health)
  134. 8.23.1 Ihealth (Andon Health) Company Information
  135. 8.23.2 Ihealth (Andon Health) Business Overview
  136. 8.23.3 Ihealth (Andon Health) COVID-19 Rapid Antigen Test Kits Sales, Value and Gross Margin (2021-2026)
  137. 8.23.4 Ihealth (Andon Health) COVID-19 Rapid Antigen Test Kits Product Portfolio
  138. 8.23.5 Ihealth (Andon Health) Recent Developments
  139. 8.24 Ellume
  140. 8.24.1 Ellume Company Information
  141. 8.24.2 Ellume Business Overview
  142. 8.24.3 Ellume COVID-19 Rapid Antigen Test Kits Sales, Value and Gross Margin (2021-2026)
  143. 8.24.4 Ellume COVID-19 Rapid Antigen Test Kits Product Portfolio
  144. 8.24.5 Ellume Recent Developments
  145. 8.25 CTK Biotech
  146. 8.25.1 CTK Biotech Company Information
  147. 8.25.2 CTK Biotech Business Overview
  148. 8.25.3 CTK Biotech COVID-19 Rapid Antigen Test Kits Sales, Value and Gross Margin (2021-2026)
  149. 8.25.4 CTK Biotech COVID-19 Rapid Antigen Test Kits Product Portfolio
  150. 8.25.5 CTK Biotech Recent Developments
  151. 8.26 Clip Health
  152. 8.26.1 Clip Health Company Information
  153. 8.26.2 Clip Health Business Overview
  154. 8.26.3 Clip Health COVID-19 Rapid Antigen Test Kits Sales, Value and Gross Margin (2021-2026)
  155. 8.26.4 Clip Health COVID-19 Rapid Antigen Test Kits Product Portfolio
  156. 8.26.5 Clip Health Recent Developments
  157. 8.27 Celltrion
  158. 8.27.1 Celltrion Company Information
  159. 8.27.2 Celltrion Business Overview
  160. 8.27.3 Celltrion COVID-19 Rapid Antigen Test Kits Sales, Value and Gross Margin (2021-2026)
  161. 8.27.4 Celltrion COVID-19 Rapid Antigen Test Kits Product Portfolio
  162. 8.27.5 Celltrion Recent Developments
  163. 8.28 BD
  164. 8.28.1 BD Company Information
  165. 8.28.2 BD Business Overview
  166. 8.28.3 BD COVID-19 Rapid Antigen Test Kits Sales, Value and Gross Margin (2021-2026)
  167. 8.28.4 BD COVID-19 Rapid Antigen Test Kits Product Portfolio
  168. 8.28.5 BD Recent Developments
  169. 8.29 AESKU.GROUP
  170. 8.29.1 AESKU.GROUP Company Information
  171. 8.29.2 AESKU.GROUP Business Overview
  172. 8.29.3 AESKU.GROUP COVID-19 Rapid Antigen Test Kits Sales, Value and Gross Margin (2021-2026)
  173. 8.29.4 AESKU.GROUP COVID-19 Rapid Antigen Test Kits Product Portfolio
  174. 8.29.5 AESKU.GROUP Recent Developments
  175. 8.30 ACCESS BIO
  176. 8.30.1 ACCESS BIO Company Information
  177. 8.30.2 ACCESS BIO Business Overview
  178. 8.30.3 ACCESS BIO COVID-19 Rapid Antigen Test Kits Sales, Value and Gross Margin (2021-2026)
  179. 8.30.4 ACCESS BIO COVID-19 Rapid Antigen Test Kits Product Portfolio
  180. 8.30.5 ACCESS BIO Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 COVID-19 Rapid Antigen Test Kits Value Chain Analysis
  2. 9.1.1 COVID-19 Rapid Antigen Test Kits Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 COVID-19 Rapid Antigen Test Kits Sales Mode & Process
  6. 9.2 COVID-19 Rapid Antigen Test Kits Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 COVID-19 Rapid Antigen Test Kits Distributors
  9. 9.2.3 COVID-19 Rapid Antigen Test Kits Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst